Tune in to our new episode on International #Myeloma Society 2025 Updates with key abstracts ranging from smoldering myeloma to relapsed/refractory myeloma with @AlGarfall! https://t.co/NtpYtVDUpB

🎙️ New episode alert! "ctDNA in DLBCL" now live on @BloodCancerTalk. Dive into the latest on circulating tumor DNA as a biomarker for diffuse large B-cell lymphoma monitoring and treatment decisions with experts @AshAlizadeh and @dgermain21! https://t.co/tnZtK2SpAl @Eddie_Cliff

Curious how ctDNA could reshape care for aggressive cancers like #DLBCL? Hear from co-founder Ash Alizadeh on its potential, from advances in detection to breakthrough clinical data. Listen here: https://t.co/i0s7snKOht @BloodCancerTalk @rajshekharucms @AshKishtagari @Eddie_Cliff

🎙️ New episode alert! "ctDNA in DLBCL" now live on @BloodCancerTalk. Dive into the latest on circulating tumor DNA as a biomarker for diffuse large B-cell lymphoma monitoring and treatment decisions with experts @AshAlizadeh and @dgermain21! https://t.co/tnZtK2SpAl @Eddie_Cliff

Don't miss our @icmlugano & @EHA_Hematology lymphoma round-up episode @BloodCancerTalk: Bispecific Bonanza with @AdrianMinson @PeterMacCC SUNMO POLARGO STARGLO R-Pola-Glo LOTIS-7 ...and more Wherever you get your podcasts #lymsm @mike_dickinson1 @rajshekharucms

Tune in to our new episode on EHA and ICML 2025 updates in #lymphoma with @AdrianMinson @PeterMacCC! https://t.co/sZdl0XYSBh Here is a clip of Dr. Minson's take on the Epcor + R-ICE data

Tune in to our new episode on EHA and ICML 2025 updates in #lymphoma with @AdrianMinson @PeterMacCC! https://t.co/sZdl0XYSBh Here is a clip of Dr. Minson's take on the Epcor + R-ICE data

🎧 NEW EPISODE ALERT! 🎧 Dive deep into follicular lymphoma management with Dr. Gilles Salles @MSKCancerCenter! From watchful waiting to bispecifics & CAR-T - we cover it all. 🔬 Key trials: RELEVANCE, GALLIUM, InMIND & more Listen now! 🎙️ @Eddie_Cliff https://t.co/alv2GpEM52

A real honour to have Prof Gilles Salles @MSKCancerCenter on @BloodCancerTalk for a masterclass on follicular lymphoma. Listen wherever you get your podcasts. @rajshekharucms @mike_dickinson1 @Cure_FL @lymphomahub #lymsm #lymphoma

🎧 NEW EPISODE ALERT! 🎧 Dive deep into follicular lymphoma management with Dr. Gilles Salles @MSKCancerCenter! From watchful waiting to bispecifics & CAR-T - we cover it all. 🔬 Key trials: RELEVANCE, GALLIUM, InMIND & more Listen now! 🎙️ @Eddie_Cliff https://t.co/alv2GpEM52

MIDAS under the Microscope: Check out our special episode unpacking MIDAS trial in newly diagnosed #MultipleMyeloma with @MeeraMohanMD! https://t.co/i0ZRHjauci

Opinion: Top Studies From EHA 2025 @CancerTherAdvsr https://t.co/HSaKBY3Xur

Missed our @young_eha session on clinical trial appraisal? Check out my short interview with @VJHemOnc on the importance of postprogression care in overall survival assessment Examples: SHINE, TRIANGLE, ZUMA-7 & TRANSFORM. https://t.co/dPwteHsawE #EHA2025 @EHA_Hematology #lymsm

Our new episode on overview of Menin Inhibitors in AML with @Doctor_E_Stein from @MSKCancerCenter just dropped! We had a great discussion on the landscape of menin inhibitors, along with some clinical pearls from Dr. Stein on management! https://t.co/EfS5chvT46 @AshKishtagari

Shamelessly stealing the concept of emergency podcasts from @RestIsPolitics but don’t worry we aren’t talking politics - we talk AQUILA, STARGLO, FDA ODAC Come into the weeds of clinical trials with us Glofitamab-GemOx for R/R DLBCL #starglo #lymsm #ODAC @csoncol @OncoAlert

New🚨 EMERGENCY PODCAST 🚨 episode @BloodCancerTalk! Following recent FDA ODAC proceedings, we dissect two pivotal trials & insights from FDA/panelists: 🔸 AQUILA: Daratumumab in high-risk SMM 🔸 STARGLO: Glofitamab in R/R DLBCL https://t.co/LYJ3IDokKZ A short clip on STARGLO:

Tune in to our new episode on management of systemic mastocytosis with Dr. Daniel DeAngelo from @DanaFarber! @AshKishtagari https://t.co/nFc8vt8IZL

Delighted to share that @BloodCancerTalk has surpassed 100,000 downloads - thanks to our guests for sharing their wisdom & our listeners for joining us. Find us at https://t.co/lz8o7jn63j or wherever you get your podcasts. @rajshekharucms @AshKishtagari #lymphoma #haematology

NEW @BloodCancerTalk episode: Dr. Piers Blombery joins us to discuss CAR Transgenic T-cell Lymphoproliferative Neoplasm - a rare complication of CAR T-cell therapy patients. Learn about clinical presentation, diagnostic workup, and future directions! https://t.co/rMBAb8URCd

Excited to share the newest @BloodCancerTalk episode! We’re breaking down the ASH 2024 myeloid updates with Dr. @jayastuMD from @MDAndersonNews . From groundbreaking research to clinical insights, this discussion is a must-listen! Tune in now! #ASH2024 @rajshekharucms